http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106177970-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P23-02 |
| filingDate | 2016-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106177970-B |
| titleOfInvention | Ropivacaine injection preparation and its preparation method and application |
| abstract | The invention discloses a kind of Ropivacaine injection preparations, form as follows: the pharmaceutically acceptable salt of Ropivacaine or Ropivacaine, glucose and/or sodium chloride and pH adjusting agent and water for injection.In addition, also disclosing the preparation method and application of said preparation.Preparation impurity content of the invention is low, and quality is stablized in placement process, and organic solvent-free, and clinical use process microbiological contamination risk reduces, for patient more safely and effectively. |
| priorityDate | 2016-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 42.